No Data
Alnylam Tumbles, BridgeBio Gains After Heart Drug Data
Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits
Alnylam Pharmaceuticals Analyst Ratings
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
BridgeBio Shares Data On Serum TTR Increase When Switching Participants From Placebo And Tafamidis To Acoramidis In ATTRibute-CM And Its Open-Label Extension; Showed A 42% Reduction In Composite CVH And ACM, And A 50% Reduction In The Cumulative...
Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday